D. Boral ARC Acquisition I Corp. Class A Ordinary Shares

Exascale Labs and D. Boral ARC Acquisition I Corp. announced that BCAR shareholders voted to approve their business combination at an extraordinary general meeting. The combined company will operate as Exascale Labs Holdings Inc. and trade on Nasdaq under the tickers XLAB and XLABW. Following redemptions, approximately $12 million remains in BCAR's trust account, satisfying the minimum cash closing condition. The parties expect to close the transaction shortly and do not anticipate pursuing additional financing before closing.

Exascale Labs and D. Boral ARC Acquisition I Corp. have scheduled an extraordinary general meeting of BCAR shareholders for July 29, 2026, to approve their proposed business combination. Shareholders of record as of July 6, 2026, are eligible to vote at the meeting, which will be held both in person at Loeb & Loeb LLP's New York office and virtually. The business combination is expected to close shortly after shareholder approval, with the combined company operating as Exascale Labs Holdings Inc. and trading on Nasdaq under the ticker symbol XLAB. A definitive proxy statement has been filed with the SEC and mailed to shareholders, who are urged to vote promptly regardless of the number of shares held.